A potential serological biomarker for inner ear pathologies: OTOLIN-1

Area of Science:

• Otorhinolaryngology
• Biochemistry
• Medical Diagnostics

Background:

• OTOLIN-1 is a protein primarily expressed in the inner ear.
• Inner ear disorders can significantly impact patient quality of life.
• Identifying reliable biomarkers for inner ear conditions is crucial for timely diagnosis and treatment.

Purpose of the Study:

• To investigate if OTOLIN-1 levels in bodily fluids can serve as a diagnostic marker for inner ear disorders.
• To compare OTOLIN-1 concentrations between patients with specific inner ear conditions and healthy controls.

Main Methods:

• Initial measurement of OTOLIN-1 in serum, urine, and saliva of patients with acute Ménière's disease and healthy subjects.
• Subsequent focus on serum OTOLIN-1 levels, comparing acute Ménière's disease, sudden hearing loss, vestibular neuritis, and healthy cohorts.
• Statistical analysis to determine significant differences in serum OTOLIN-1 concentrations.

Main Results:

• Serum OTOLIN-1 levels were significantly higher in patients with acute Ménière's disease and sudden hearing loss compared to healthy individuals.
• No significant difference in serum OTOLIN-1 was observed between patients with vestibular neuritis and the control group.
• Serum OTOLIN-1 demonstrated potential as a reliable diagnostic parameter.

Conclusions:

• Elevated serum OTOLIN-1 levels show promise as a biomarker for acute inner ear disorders.
• This finding supports the potential use of serum OTOLIN-1 for diagnosing acute Ménière's disease and sudden hearing loss.
• Further research may validate OTOLIN-1 as a routine diagnostic tool for specific inner ear conditions.